785
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Caffeoyl phenols and alkamides of cultivated Echinacea purpurea and Echinacea atrorubens var. paradoxa

, &
Pages 835-840 | Received 21 May 2008, Accepted 22 Jun 2008, Published online: 02 Jul 2009
 

Abstract

Echinacea purpurea (L.) Moench was recently introduced into Taiwan. In the present study, the biomass, the contents of caffeoyl phenols, and the content of dodeca-2E,4E,8Z,10E-tetraenoic acid isobutylamide plus dodeca-2E,4E,8Z,10Z-tetraenoic acid isobutylamide (alkamides 8 and 9 respectively,) of locally selected line CLS-P2 and two introduced cultivars Magnus and White Swan of E. purpurea and an introduced E. atrorubens var. paradoxa were compared. The results indicated that both biomass and phytoactive constituents varied considerably among the introduced cultivars and selected line. Line CLS-P2 grew better and produced more aerial and ground parts than introduced cultivars Magnus and White Swan. It also produced more caffeoyl phenols, particularly cichoric acid and caftaric acid in its leaves than Magnus and White Swan. All the E. purpurea cultivars and line produced same amounts of alkamides 8 and 9 in their flower heads and leaves. But White Swan produced more alkamides 8 and 9 in its roots than CLS-P2 and Magnus. Line CLS-P2 was less homogenous in genetic background as compared to the introduced cultivars. E. atrorubens var. paradoxa also grew well in Taiwan, but it produced less aerial and ground dry mass than E. purpurea. E. atrorubens var. paradoxa produced more echinacoside in its flower heads, leaves, and root parts, while E. purpurea plants had more cichoric acid and caftaric acid in their flower heads and leaves. E. atrorubens var. paradoxa also produced more alkamides 8 and 9 in flower heads and leaves, while E. purpurea produced more alkamides 8 and 9 in roots.

Declaration of interest: We gratefully acknowledge financial support (GB91206) from the Council of Agriculture, ROC. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.